Post Job

Halozyme Executives

Here are further demographic highlights of the leadership team:
  • The Halozyme executive team is 43% female and 57% male.
  • 62% of the management team is White.
  • 7% of Halozyme management is Hispanic or Latino.
  • 10% of the management team is Black or African American.
Work At Halozyme?
Share Your Experience

Rate Halozyme's leaders' effectiveness in guiding the company.

Zippia waving zebra
Name & TitleBio
Gregory Frost

Founder

Helen I. Torley

Board Member

Helen Torley is a President/CEO at HALOZYME THERAPEUTICS, INC.; Board Member at HALOZYME THERAPEUTICS, INC.; and Board Member at QUEST DIAGNOSTICS INC. She has experience at Bristol Myers Squibb and has worked as Exec VP/Chief Commercial Ofcr at Onyx Pharmaceuticals, Inc. and Board Member at RELYPSA INC. Helen works or has worked at Novartis and works or has worked as VP:Medical Affairs at Novartis, VP/Gen Mgr:Bone Health at Amgen, and Head:Cardiovascular at Bristol Myers Squibb. She studied at UNIVERSITY OF GLASGOW.

Connie L. Matsui

Chairman of The Board

Connie L. Matsui's LinkedIn

Matthew L. Posard

Board Member

Matthew L. Posard's LinkedIn

Bernadette Mary Connaughton

Board Member

Bernadette Mary Connaughton's LinkedIn

James M. Daly

Board Member

James M. Daly's LinkedIn

Akiko Moni Miyashita

Board Member

Jeffrey William Henderson

Board Member

Jeffrey William Henderson's LinkedIn

Steve Knowles

Chief Medical Officer

Steve Knowles's LinkedIn

Amy Marinne Fox

Vice President-Human Resources

Amy Marinne Fox's LinkedIn

Do you work at Halozyme?

Does leadership effectively guide Halozyme toward its goals?

Halozyme Jobs

Halozyme Founders

Name & TitleBio
Gregory Frost

Founder

Halozyme Board Members

Name & TitleBio
Helen I. Torley

Board Member

Helen Torley is a President/CEO at HALOZYME THERAPEUTICS, INC.; Board Member at HALOZYME THERAPEUTICS, INC.; and Board Member at QUEST DIAGNOSTICS INC. She has experience at Bristol Myers Squibb and has worked as Exec VP/Chief Commercial Ofcr at Onyx Pharmaceuticals, Inc. and Board Member at RELYPSA INC. Helen works or has worked at Novartis and works or has worked as VP:Medical Affairs at Novartis, VP/Gen Mgr:Bone Health at Amgen, and Head:Cardiovascular at Bristol Myers Squibb. She studied at UNIVERSITY OF GLASGOW.

Connie L. Matsui

Chairman of The Board

Connie L. Matsui's LinkedIn

Matthew L. Posard

Board Member

Matthew L. Posard's LinkedIn

Bernadette Mary Connaughton

Board Member

Bernadette Mary Connaughton's LinkedIn

James M. Daly

Board Member

James M. Daly's LinkedIn

Akiko Moni Miyashita

Board Member

Jeffrey William Henderson

Board Member

Jeffrey William Henderson's LinkedIn

Steve Knowles

Chief Medical Officer

Steve Knowles's LinkedIn

Jean-Pierre Bizzari

Board Member

Jean-Pierre Bizzari's LinkedIn

Kathryn Falberg

Board Member

Halozyme Executives FAQs

Zippia gives an in-depth look into the details of Halozyme, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Halozyme. The employee data is based on information from people who have self-reported their past or current employments at Halozyme. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Halozyme. The data presented on this page does not represent the view of Halozyme and its employees or that of Zippia.

Halozyme may also be known as or be related to HALOZYME THERAPEUTICS INC., Halozyme, Halozyme Inc, Halozyme Therapeutics Inc, Halozyme Therapeutics, Inc. and Halozyme, Inc.